Rethinking pragmatic randomised controlled trials: introducing the "cohort multiple randomised controlled trial" design
BMJPublished 19 March 2010
Clare Relton, David Torgerson, Alicia O’Cathain, Jon Nicholl
Citations499
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Clare Relton and colleagues outline the new “cohort multiple randomised controlled trial” design, which could help address the problems associated with existing approaches in pragmatic trials.
Abstract
Pragmatic trials are important for informing routine clinical practice, but current designs have shortcomings. Clare Relton and colleagues outline the new “cohort multiple randomised controlled trial” design, which could help address the problems associated with existing approaches
Keywords
Decision SciencesMedicineEconomics, Econometrics and Finance
Journal of Clinical EpidemiologyA pragmatic–explanatory continuum indicator summary (PRECIS): a tool to help trial designers
1,398 Citations2009Kevin E. Thorpe, Merrick Zwarenstein +9 more
A tool to assist trialists in making design decisions that are consistent with their trial's stated purpose is proposed, with 10 key domains and which identifies criteria to help researchers determine how pragmatic or explanatory their trial is.
Journal of Clinical EpidemiologyExplanatory and Pragmatic Attitudes in Therapeutical Trials
1,260 Citations2009Daniel Schwartz, J Lellouch
Most therapeutic trials are inadequately formulated from the earliest stages of their conception, and it often occurs that one type of approach is ethically less defensible than the other, or may even be ruled out altogether on ethical grounds.
New England Journal of MedicineA New Design for Randomized Clinical Trials
1,039 Citations1979Marvin Zelen
This paper proposes a new method for planning randomized clinical trials, especially suited to comparison of a best standard or control treatment with an experimental treatment, which has the advantage that, before providing consent, a patient will know whether an experimental therapy is to be used.
TrialsWhat influences recruitment to randomised controlled trials? A review of trials funded by two UK funding agencies
971 Citations2006Alison McDonald, Rochelle Knight +9 more
BMJValidity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses
946 Citations2003Fujian Song, Douglas G Altman +2 more
Results of adjusted indirect comparison usually, but not always, agree with those of head to head randomised trials The validity ofadjusted indirect comparisons depends on the internal validity and similarity of the trials involved.
Journal of Clinical EpidemiologyBarriers to Participation in Randomised Controlled Trials
912 Citations1999Sue Ross, Adrian Grant +4 more
To overcome barriers to clinician recruitment, the trial should address an important research question and the protocol and data collection should be as straightforward as possible.
BMJPatient preferences and randomised clinical trials.
507 Citations1989Chris R. Brewin, Clare Bradley
The child should be examined but not without the knowledge and agreement of a parent (or the order of a court) and in an environment where the child can be comfortable?not behind screens in open wards or in police stations.
Health Technology AssessmentChoosing between randomised and non-randomised studies: a systematic review.
312 Citations1998Britton, McKee +4 more
BMJPatients' preferences within randomised trials: systematic review and patient level meta-analysis
295 Citations2008Elaine M. Hay
Preference among patients in musculoskeletal trials are associated with treatment effects and in open randomised trials, preferences should be ascertained before randomisation.
Health Technology AssessmentThe causes and effects of socio-demographic exclusions from clinical trials
247 Citations2005C. J. Bartlett, Lesley Doyal +5 more
The effects of statins on women and older people and the relationship of absolute effectiveness outcomes with underlying risk levels of disease events was modelled, examining the likely effects of trial exclusions.
Contemporary Clinical TrialsReview of randomised trials using the post-randomised consent (Zelen's) design
136 Citations2006Joy Adamson, Sarah Cockayne +2 more
Zelen's method, if carefully used, can avoid 'resentful demoralisation' and the Hawthorne effect biasing a trial and it was found that crossover was not a problem for most trials.
Designing Randomised Trials in Health, Education and the Social Sciences: An Introduction
136 Citations2008David Torgerson, Carole Torgerson
American Journal of Public Health and the Nations HealthSuburbanization and Suburbia
128 Citations1955Coleman Woodbury
Canadian Medical Association JournalIs there another way to take account of noncompliance in randomized controlled trials?
126 Citations2006Catherine Hewitt
This work states that some participants invited to go through a screening program may not receive the treatment or intervention to which they were randomly allocated, and this should not be considered a cause for concern.
BMJRepresentation of South Asian people in randomised clinical trials: analysis of trials' data
115 Citations2003Samantha J. Mason, Mahvash Hussain-Gambles +3 more
To determine the proportion of South Asian participants (the biggest minority ethnic group in Britain) included in clinical trials, the ethnicity profile of six clinical trials recently conducted by the Northern and Yorkshire Clinical Trials and Research Unit, University of Leeds was investigated.
Methods of Information in MedicineComprehensive Cohort Study: An Alternative to Randomized Consent Design in a Breast Preservation Trial
84 Citations1985Manfred Olschewski, H Scheurlen
If in a clinical trial only few patients consent to randomization, all those patients meeting the clinical inclusion criteria should be considered for analysis, and conventionally randomized trials with the inclusion of patients having therapeutic preferences appear to be preferable.
Contemporary Clinical TrialsRandomized consent designs in randomized controlled trials: Systematic literature search
39 Citations2006Ron Schellings, Alfons G.H. Kessels +3 more
Journal of Health Services Research & PolicyAdapting the randomized consent (Zelen) design for trials of behavioural interventions for chronic disease: feasibility study
37 Citations2005Rona Campbell, T. J. Peters +3 more
A pre-randomization design that would overcome ethical and methodological problems associated with the conventional Zelen design, and permit the rigorous evaluation of a complex package of care, involving physical therapy and behavioural changes, for patients with painful patello-femoral osteoarthritis of the knee joint is developed.
BMJShould you tell patients about beneficial treatments that they cannot have? No
15 Citations2007John Firth
No healthcare system can afford to pay for all available treatments, but doctors have a duty to tell patients about unfunded drugs, but John Firth argues that it will cause them harm.
BMJShould you tell patients about beneficial treatments that they cannot have? Yes
13 Citations2007Robert Marcus
No healthcare system can afford to pay for all available treatments, but doctors have a duty to tell patients about unfunded drugs, but John Firth argues that it will cause them harm.
White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)A new design for pragmatic randomised controlled trials: a 'Patient Cohort' RCT of treatment by a homeopath for menopausal hot flushes
2 Citations2009Clare Relton
A critique of the methods used in existing clinical trial designs was undertaken and a new clinical trial design that has the potential to meet all twelve key criteria was derived, the ‘Patient Cohort’ RCT design.